Limitations to antiarrhythmic drug use in patients with atrial fibrillation
- World Atrial Fibrillation Awareness Day - It's About Time! Lakkireddy, Dhanunjaya // JAFIB: Journal of Atrial Fibrillation;
The author reflects on the prevalence of Atrial Fibrillation (AF) which have increased and relatively not common before the age of 60 years affecting 10% of population in the U.S. He states that coronary artery disease happens due to functional stenosis or mechanical obstruction of coronary...
- Murmurs about the heart. Laborde, Karen L. // New Orleans Magazine;Feb2000, Vol. 34 Issue 5, p28
Focuses on the prevention and treatment of coronary-artery disease. INSET: Risk Factors for Coronary-Artery Disease.
- Comorbidities Complicate a Diabetic Man's Care. Steingart, Richard M. // Cortlandt Forum;3/25/2003, Vol. 16 Issue 3, p102
Discusses the management of coronary artery disease. Findings of symptom-limited stress test; Importance of weight loss in diabetic patients; Frequency of prevention services in physician specialties.
- Coronary disease. Hart, Julian Tudor // British Medical Journal (Clinical Research Edition);7/31/1982, Vol. 285 Issue 6338, p345
Examines the clinical management for coronary diseases. Preventive mechanism for the disease; Role of the cardiologist in ensuring proper medical care for affected patients; Signs and symptoms of coronary diseases.
- Atrial fibrillation after surgical revascularization: is there any difference between on-pump and off-pump? Enc, Yavuz; Ketenci, Bulent; Ozsoy, Deniz; Camur, Gercek; Kayacıoglu, Ilyas; Terzi, Sait; Cicek, Sertac // European Journal of Cardio-Thoracic Surgery;Dec2004, Vol. 26 Issue 6, p1129
Abstract: Objective: Postoperative atrial fibrillation (AF) is still frequent complication after cardiac surgery in spite of the improvements in the surgical procedures. There is still controversy whether or not, the absence of cardiopulmonary bypass results in a lower incidence of AF. Methods:...
- Direct Thrombin Inhibitors Soon Available to Prevent Stroke in Atrial Fibrillation Patients. Fink, Matthew E. // Neurology Alert;Nov2011, Vol. 30 Issue 3, p20
The article discusses the addition of two direct thrombin inhibitors to prevent stroke in patients with atrial fibrillation. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF) was designed to test rivaroxaban in a double blind trial against warfarin. Also, Apixaban versus...
- Abstracts of the 2008th Encouragement Award's Memorial Lecture. // Journal of Nippon Medical School;2009, Vol. 76 Issue 1, p38
The article offers information on the study of substrates for atrial fibrillation (AF). Researchers conducted the trial of AF in hearts of myocardial infarction patients. It was discovered that heterogeneous pulmonary vein myocardial cell repolarization and heterogeneous sympathetic...
- INTRODUCTION. Myerburg, Robert J. // Journal of Cardiovascular Pharmacology & Therapeutics;Jan2001, Vol. 6 Issue 1, p67
The article presents information on the symposium "Designing Antiarrhythmic Therapy--Lessons from the 20th Century." Primary issues of antiarrhythmic strategies include effect, safety, and tolerance. The symposium begins with physician John Camm's discussion on clinical trials, focusing...
- Experts debate using risk or expected benefit for determining when to start stain therapy. // Formulary;Nov99, Vol. 34 Issue 11, p908
Presents perspectives on the use of statin therapy for primary prevention of coronary artery diseases. Initiation of statins for primary prevention guided by the risk of future cardiovascular events; Multifactorial approach to guide treatment decisions; Statin therapy guided by the expected...